Filing Flows › Comparisons › ABEO vs OCUL
Abeona Therapeutics vs Ocular Therapeutix: ABEO and OCUL compared
Abeona Therapeutics is the larger company: $13.5M of revenue in its latest quarter (Q3 2026) against $12.9M for Ocular Therapeutix (Q3 2026). Abeona Therapeutics is more profitable, with an operating margin of -96.4% against -760.1%.
Where the money goes: ABEO and OCUL
Abeona Therapeutics (ABEO) · Q3 2026
Abeona Therapeutics, Q3 2026: revenue $13.5M, operating margin -96.4%, net loss $4.8M, operating cash flow −$8.3M. The chart follows the revenue to costs, profit and cash.
Ocular Therapeutix (OCUL) · Q3 2026
Ocular Therapeutix, Q3 2026: revenue $12.9M (-12% year over year), operating margin -760.1%, net loss $94.8M, operating cash flow −$65.6M. The chart follows the revenue to costs, profit and cash.
| Abeona Therapeutics (ABEO) | Ocular Therapeutix (OCUL) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $13.5M | $12.9M |
| Revenue growth, Y/Y | — | -12% |
| Operating margin | -96.4% | -760.1% |
| Net earnings | −$4.8M | −$94.8M |
| Net margin | -35.6% | -736.2% |
| Operating cash flow | −$8.3M | −$65.6M |
Questions
Which is bigger, Abeona Therapeutics or Ocular Therapeutix?
Abeona Therapeutics is the larger company: $13.5M of revenue in its latest quarter (Q3 2026) against $12.9M for Ocular Therapeutix (Q3 2026).
Is Abeona Therapeutics or Ocular Therapeutix growing faster?
Abeona Therapeutics is more profitable, with an operating margin of -96.4% against -760.1%.
More: Abeona Therapeutics earnings · how Abeona Therapeutics makes money · Ocular Therapeutix earnings · how Ocular Therapeutix makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 9, 2026; 10-Q filed Nov 9, 2026). Fiscal quarters can end on different dates. Not investment advice.